Splenic infarction

Global Heart Hub's real-life data highlights need for patient-centered management of unhealthy cholesterol

Retrieved on: 
Mittwoch, Mai 8, 2024
Mortality, Public, Patient, Stroke, Risk, ASCVD, Travel, Death, Research, IPEC, Human, Nation, Initial, Splenic infarction, Data analysis, Injection, Pharmaceutical industry

The findings, presented at ISPOR 2024, highlight several barriers that hinder patient-centred care in the management of unhealthy cholesterol (low-density lipoprotein cholesterol or LDL–C) and shed light on a persistent care gap in atherosclerotic cardiovascular disease (ASCVD).

Key Points: 
  • The findings, presented at ISPOR 2024, highlight several barriers that hinder patient-centred care in the management of unhealthy cholesterol (low-density lipoprotein cholesterol or LDL–C) and shed light on a persistent care gap in atherosclerotic cardiovascular disease (ASCVD).
  • The ISPOR data analysis focused on understanding the experiences of participants from the United States through interviews with 16 patients.
  • Global Heart Hub is proud to be at the forefront in collecting patient experience data in this population.
  • As part of the evolution of Invisible Nation and supported by the global patient community, a Global Cholesterol Action Plan was created to continue to activate change to address unhealthy cholesterol levels.

ReNew Health to Pay $7 Million to Settle First-of-its-Kind COVID-19 False Claims Act Case

Retrieved on: 
Dienstag, April 30, 2024
SNF, Courage, CMS, Person, Learning, Pneumonia, State, Reed, Nursing, Medicaid, Medicare (United States), False Claims Act, Injury, Senior, COVID-19, Splenic infarction, Medicare, Judgement, Government, Pharmaceutical industry

MINNEAPOLIS, Minn., April 29, 2024 /PRNewswire-PRWeb/ -- Zimmerman Reed announced today that the United States and the State of California reached a $7 million settlement with ReNew Health Group LLC, ReNew Health Consulting Services LLC, and its owner-CEO and its COO to resolve False Claims Act allegations filed by Zimmerman Reed's whistleblower clients. ReNew Health, the owner and operator of dozens of nursing facilities throughout California, allegedly submitted millions of dollars of fraudulent claims to Medicare and California Medicaid since March 2020 under a scheme involving a COVID-19 waiver program.

Key Points: 
  • Zimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program.
  • "This case emphasizes the vital contribution that whistleblowers can make in exposing healthcare fraud," said June Hoidal, chair of Zimmerman Reed's Whistleblower practice.
  • "The courage of our clients who reported improper Medicare and Medicaid claims was instrumental in bringing this case to light and securing a just result."
  • The federal False Claims Act and its state law equivalents empower private citizens to sue on the government's behalf against persons who present false claims for payment under government contracts or programs.

Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies

Retrieved on: 
Montag, April 29, 2024
Inflammation, Coronary artery disease, Holon, Heart, Newsweek, Disease, Cardiovascular Research, Stroke, Diagnosis, Digital health, Patient, Splenic infarction, Cari, JACC, European Heart Journal, CCTA, Algorithm, Health, Medical device

OXFORD, England, April 29, 2024 /PRNewswire/ -- Caristo Diagnostics , a leading cardiac disease diagnostics company, has been named by Newsweek as one of World's Best Digital Health Companies in diagnostics.

Key Points: 
  • OXFORD, England, April 29, 2024 /PRNewswire/ -- Caristo Diagnostics , a leading cardiac disease diagnostics company, has been named by Newsweek as one of World's Best Digital Health Companies in diagnostics.
  • Newsweek's inaugural ranking of the World's Best Digital Health Companies includes 400 companies in seven segments including diagnostics, health records, medical management and telehealth.
  • The ranking is based on in-depth analysis of thousands of companies' financial performance and traffic data for websites and apps.
  • "Caristo is honored to be recognized by Newsweek as one of the World's Best Digital Health Companies.

Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies

Retrieved on: 
Montag, April 29, 2024
Inflammation, Coronary artery disease, Holon, Heart, Newsweek, Disease, Cardiovascular Research, Stroke, Diagnosis, Digital health, Patient, Splenic infarction, Cari, JACC, European Heart Journal, CCTA, Algorithm, Health, Medical device

OXFORD, England, April 29, 2024 /PRNewswire/ -- Caristo Diagnostics , a leading cardiac disease diagnostics company, has been named by Newsweek as one of World's Best Digital Health Companies in diagnostics.

Key Points: 
  • OXFORD, England, April 29, 2024 /PRNewswire/ -- Caristo Diagnostics , a leading cardiac disease diagnostics company, has been named by Newsweek as one of World's Best Digital Health Companies in diagnostics.
  • Newsweek's inaugural ranking of the World's Best Digital Health Companies includes 400 companies in seven segments including diagnostics, health records, medical management and telehealth.
  • The ranking is based on in-depth analysis of thousands of companies' financial performance and traffic data for websites and apps.
  • "Caristo is honored to be recognized by Newsweek as one of the World's Best Digital Health Companies.

New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol, and Weight Using Mobile Technology

Retrieved on: 
Dienstag, April 23, 2024
Cardiology, Health, Medical Devices, Health Technology, Wearables, Mobile Technology, Technology, Apps, Applications, Mobile, Wireless, Stroke, American College, SBP, Risk, Blood pressure, CVD, Heart, BMI, Death, Conference, Artificial intelligence, Heart rate, SVP, Patient, Splenic infarction, Cholesterol, Physician, Medicare, LDL, Cardiovascular disease, BP, Ageing

The study observed 8,148 Hello Heart users aged 65 and over who were equipped with the Hello Heart connected monitor and mobile app.

Key Points: 
  • The study observed 8,148 Hello Heart users aged 65 and over who were equipped with the Hello Heart connected monitor and mobile app.
  • Study participants showed a 45% higher engagement rate compared to Hello Heart users younger than 65.
  • “Results from this study challenge the assumption that our aging population struggles to use smartphones or are resistant to using technology to manage their health,” said Edo Paz, MD, SVP, Medical Affairs, Hello Heart.
  • “There’s a significant untapped opportunity to engage this age group with scalable mobile technology to help them better understand their CVD risk and take steps to improve their heart health.”

Drug Infusion Systems Global Market Report 2024: Demand for Personalized Medicine and Adaptive Dosing Spurs Growth - Long-term Forecast to 2028 and 2033 - ResearchAndMarkets.com

Retrieved on: 
Donnerstag, April 18, 2024
Health, Pharmaceutical, International Diabetes Federation, Conditional sentence, Cancer, IDF, Informatics, Hospital, Diabetes, EHR, Health care, EMR, Paratriathlon, ADT, Stroke, Amputation, Health information management, Patient, Splenic infarction, Kidney, Prevalence, Ageing, Medical device

The drug infusion systems market is expected to see strong growth in the next few years.

Key Points: 
  • The drug infusion systems market is expected to see strong growth in the next few years.
  • Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period.
  • Global Drug Infusion Systems Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
    6.1.
  • Global Drug Infusion Systems Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

2024 'State of the Air' Report Reveals Most 'Hazardous' Air Quality Days in 25 Years

Retrieved on: 
Mittwoch, April 24, 2024
Climate change, Smog, Atmosphere of Earth, City, EPA, Weather, Lung cancer, Health, Diabetes, American Lung Association, Wildfire, Ozone, History, Stroke, Splenic infarction, Child, Annual report, Asthma, Soot, Air pollution, Coal

CHICAGO, April 24, 2024 /PRNewswire/ -- The American Lung Association's new "State of the Air" report reveals that spikes in deadly particle pollution are the most severe they've been in the history of the report. According to the new report, people in the U.S. experienced the most days with "very unhealthy" and "hazardous" air quality due to particle pollution in 25 years. In total, the report finds that 131 million people (39%) are living in areas with unhealthy levels of air pollution.

Key Points: 
  • According to the new report, people in the U.S. experienced the most days with "very unhealthy" and "hazardous" air quality due to particle pollution in 25 years.
  • In total, the report finds that 131 million people (39%) are living in areas with unhealthy levels of air pollution.
  • This year's report includes the most recent quality-assured air quality data from 2020-2022 and is updated to reflect the new annual particle pollution standard that the U.S. Environmental Protection Agency (EPA) finalized in February 2024.
  • "We have seen impressive progress in cleaning up air pollution over the last 25 years, thanks in large part to the Clean Air Act.

Surrey Cardiovascular Clinic and Caristo Diagnostics Launch Employee Heart Wellness and Disease Prevention Program for UK Employers

Retrieved on: 
Dienstag, April 23, 2024
University, Cancer, NHS, Risk, Coronary artery disease, CDC, Heart, VCL, MD, Mace, Partnership, Research, MRCP, Atherosclerosis, Patient, Splenic infarction, Death, Chest pain, Artery, Plaque, Imaging, CCTA

OXFORD, England and SURREY, England , April 23, 2024 /PRNewswire/ -- Surrey Cardiovascular Clinic (SCVC), Southern England's leading centre of excellence for the prevention and treatment of cardiovascular and cancer issues, has partnered with Imaging provider VCL SURREY and Caristo Diagnostics, a leading cardiac disease diagnostics company, to offer the novel CaRi-Heart® AI technology to predict patients' risk of developing potentially fatal coronary artery disease.

Key Points: 
  • SCVC will provide the CaRi-Heart AI-based cardiac assessment as a central part of the organisations 's employee wellness initiative for UK employers.
  • In combination with the programme's other tests, Cari-Heart provides the ability to predict future heart attacks and atherosclerosis many years before symptoms occur.
  • We are pleased to announce our partnership with Surrey Cardiovascular Clinic and their imaging partner VCL Surrey to enhance accessibility to CaRi-Heart technology for employees throughout the UK," said Frank Cheng, CEO of Caristo Diagnostics.
  • The CaRi-Heart technology is currently in clinical use in various NHS and private hospitals in the UK, as well as within the EU and Australia.

Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024

Retrieved on: 
Donnerstag, April 11, 2024
Capital market, Conference, Catalog, Webcast, Stroke, Patient, Splenic infarction, Death, Noble, Therapy, Q&A, Security (finance)

The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience.

Key Points: 
  • The formal presentation will feature a fireside style Q&A session with questions welcome from the live virtual audience.
  • Attendees interested in viewing the live presentation can register for this event, at no cost, here: Virtual Healthcare Equity Conference Registration
    Scheduled 1x1 meetings with our management are also available for registered, qualified investor attendees.
  • Please contact your Noble Capital Markets representative or the Cadrenal's Investor Relations team at [email protected] .
  • The webcast will be archived on the company's website and on Channelchek.com for 90 days following the event.

Powerful Medical's AI Breakthrough Marks a New Dawn in Heart Attack Diagnostics with EIC Support Doubles Sensitivity in Identifying Acute Coronary Occlusion on 12-Lead ECG

Retrieved on: 
Montag, März 18, 2024
European Innovation Council, Longevity, Medicine, Cardiology, Patient, Splenic infarction, MD, EIC, Accelerator, European Investment Bank, Heart, EIB, FDA, Health, Medical device

With a landmark advancement in medical diagnostics, Powerful Medical has distinguished itself within the competitive digital health landscape.

Key Points: 
  • With a landmark advancement in medical diagnostics, Powerful Medical has distinguished itself within the competitive digital health landscape.
  • At the core of its mission, Powerful Medical introduces the PMcardio platform, a CE-certified medical device leveraging proprietary AI to analyze electrocardiograms (ECGs) with remarkable precision.
  • This platform is capable of diagnosing heart attacks — specifically, occlusion myocardial infarctions — significantly earlier and with double the sensitivity compared to the current standard of care.
  • - Robert Herman, MD, Chief Medical Officer
    As Powerful Medical begins its Series A fundraising, the EIC Accelerator's grant and investment endorse the company's vision and technology.